These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 37834235)
1. Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients. Herrera-Imbroda J; Flores-López M; Requena-Ocaña N; Araos P; García-Marchena N; Ropero J; Bordallo A; Suarez J; Pavón-Morón FJ; Serrano A; Mayoral F; Rodríguez de Fonseca F Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834235 [TBL] [Abstract][Full Text] [Related]
2. Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants. Romero-Sanchiz P; Nogueira-Arjona R; Pastor A; Araos P; Serrano A; Boronat A; Garcia-Marchena N; Mayoral F; Bordallo A; Alen F; Suárez J; de la Torre R; Pavón FJ; Rodríguez de Fonseca F Neuropharmacology; 2019 May; 149():212-220. PubMed ID: 30822499 [TBL] [Abstract][Full Text] [Related]
3. Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder. Herrera-Imbroda J; Flores-López M; Requena-Ocaña N; Araos P; Ropero J; García-Marchena N; Bordallo A; Suarez J; Pavón-Morón FJ; Serrano A; Mayoral F; Rodríguez de Fonseca F Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298321 [TBL] [Abstract][Full Text] [Related]
4. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating? Ribot R; Ouyang B; Kanner AM Epilepsy Behav; 2017 May; 70(Pt A):5-9. PubMed ID: 28407526 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy of atypical antipsychotics in depressive syndromes]. Quintin P; Thomas P Encephale; 2004; 30(6):583-9. PubMed ID: 15738862 [TBL] [Abstract][Full Text] [Related]
6. Antidepressants for people with epilepsy and depression. Maguire MJ; Marson AG; Nevitt SJ Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531 [TBL] [Abstract][Full Text] [Related]
7. Antidepressants for people with epilepsy and depression. Maguire MJ; Weston J; Singh J; Marson AG Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360 [TBL] [Abstract][Full Text] [Related]
8. [Selective serotonin reuptake inhibitors and newer antidepressive substances in child and adolescent psychiatry]. Heiser P; Remschmidt H Z Kinder Jugendpsychiatr Psychother; 2002 Aug; 30(3):173-83. PubMed ID: 12227220 [TBL] [Abstract][Full Text] [Related]
9. [Mechanism of action of antidepressant drugs: importance of genetically modified mice in the pharmacological in vivo approach]. Gardier A Therapie; 2005; 60(5):469-76. PubMed ID: 16433012 [TBL] [Abstract][Full Text] [Related]
10. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder. Khandker RK; Kruzikas DT; McLaughlin TP J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572 [TBL] [Abstract][Full Text] [Related]
11. [Use of antidepressant drugs in schizophrenic patients with depression]. Micallef J; Fakra E; Blin O Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628 [TBL] [Abstract][Full Text] [Related]
12. Other Antidepressants. Schwasinger-Schmidt TE; Macaluso M Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544 [TBL] [Abstract][Full Text] [Related]
13. The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients. Alexopoulos GS; Katz IR; Reynolds CF; Carpenter D; Docherty JP; Postgrad Med; 2001 Oct; Spec No Pharmacotherapy():1-86. PubMed ID: 17205639 [TBL] [Abstract][Full Text] [Related]
14. [Antidepressants consumption in the global population in France]. Olié JP; Elomari F; Spadone C; Lépine JP Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542 [TBL] [Abstract][Full Text] [Related]
15. Antidepressants for the treatment of depression in people with cancer. Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011006. PubMed ID: 29683474 [TBL] [Abstract][Full Text] [Related]
16. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA. Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116 [TBL] [Abstract][Full Text] [Related]
17. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)]. Hjalmarsson L; Corcos M; Jeammet P Encephale; 2005; 31(3):309-16. PubMed ID: 16142045 [TBL] [Abstract][Full Text] [Related]
18. Mice lacking the serotonin 5-HT2B receptor as an animal model of resistance to selective serotonin reuptake inhibitors antidepressants. Diaz SL; Narboux-Nême N; Boutourlinsky K; Doly S; Maroteaux L Eur Neuropsychopharmacol; 2016 Feb; 26(2):265-279. PubMed ID: 26727039 [TBL] [Abstract][Full Text] [Related]
19. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT. Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145 [TBL] [Abstract][Full Text] [Related]
20. Does the use of SSRIs reduce medical care utilization and expenditures? Chung S J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]